Operating Margin in % of C4 Therapeutics, Inc. from 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
C4 Therapeutics, Inc. quarterly/annual Operating Margin history and change rate from 2021 to Q3 2025.
  • C4 Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2025 was -431 %, a 21.6% decline year-over-year.
  • C4 Therapeutics, Inc. annual Operating Margin for 2024 was -336 %, a 49.8% increase from 2023.
  • C4 Therapeutics, Inc. annual Operating Margin for 2023 was -670 %, a 60.8% decline from 2022.
  • C4 Therapeutics, Inc. annual Operating Margin for 2022 was -417 %, a 132% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

C4 Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -431 -76.6 -21.6% Jul 1, 2025 Sep 30, 2025
Q2 2025 -361 +43.7 +10.8% Apr 1, 2025 Jun 30, 2025
Q1 2025 -293 +381 +56.5% Jan 1, 2025 Mar 31, 2025
Q4 2024 -336 +334 +49.8% Oct 1, 2024 Dec 31, 2024
Q3 2024 -354 +333 +48.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -405 +497 +55.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 -674 -180 -36.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -670 -253 -60.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -687 Jul 1, 2023 Sep 30, 2023
Q2 2023 -902 Apr 1, 2023 Jun 30, 2023
Q1 2023 -494 Jan 1, 2023 Mar 31, 2023
Q4 2022 -417 Oct 1, 2022 Dec 31, 2022

C4 Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -336 +334 +49.8% Jan 1, 2024 Dec 31, 2024
2023 -670 -253 -60.8% Jan 1, 2023 Dec 31, 2023
2022 -417 -237 -132% Jan 1, 2022 Dec 31, 2022
2021 -179 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.